Ex-Date | Pay Date | Amount | Change |
---|---|---|---|
CN¥0.126 | -86.88% | ||
CN¥0.126 | -86.88% | ||
CN¥0.96 | 166.67% | ||
CN¥0.96 | 166.67% | ||
CN¥0.36 | -31.56% | ||
CN¥0.526 | -67.41% | ||
CN¥1.614 | 0.25% | ||
CN¥1.61 | 67.71% | ||
CN¥0.96 | 0% | ||
CN¥0.96 |
Shandong Buchang Pharmaceuticals Co Ltd Class A pays a dividend yield (FWD) of 0.74%.
- ISIN
- WKN
- Symbol / Exchange
- / XSHG
- Value
- €2.16
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
China
- Dividend Currency
- Chinese Yuan
- Within the last 12 months, Shandong Buchang Pharmaceuticals Co Ltd Class A paid a dividend of CN¥0.13. For the next 12 months, Shandong Buchang Pharmaceuticals Co Ltd Class A is expected to pay a dividend of CN¥0.13. This corresponds to a dividend yield of approximately 0.74%.
- The dividend yield of Shandong Buchang Pharmaceuticals Co Ltd Class A is currently 0.74%.
- Shandong Buchang Pharmaceuticals Co Ltd Class A pays annually dividends. Payout is in August.
- The next dividend for Shandong Buchang Pharmaceuticals Co Ltd Class A is expected in August.
- Within the last 10 years, Shandong Buchang Pharmaceuticals Co Ltd Class A has paid dividends in 8 of them.
- Dividends of CN¥0.13 are expected for the next 12 months. This corresponds to a dividend yield of 0.74%.
- Shandong Buchang Pharmaceuticals Co Ltd Class A is assigned to the sector "Health Care".
- The last stock split of Shandong Buchang Pharmaceuticals Co Ltd Class A was on 19 August 2019 in the ratio 1:1.
- To receive the last dividend of Shandong Buchang Pharmaceuticals Co Ltd Class A on 20 August 2024 in the amount of CN¥0.13 you had to have the stock in your portfolio before the ex-day on 20 August 2024.
- The last dividend was paid on 20 August 2024.
- In 2022, dividends of CN¥0.36 were paid by Shandong Buchang Pharmaceuticals Co Ltd Class A.
- Dividends from Shandong Buchang Pharmaceuticals Co Ltd Class A are paid in Chinese Yuan.
- The headquarters of Shandong Buchang Pharmaceuticals Co Ltd Class A is located in China.